Takeda Pharmaceutical
Kerry Eardley is an accomplished finance professional with extensive experience in financial strategy, audit, and controllership roles. As Associate Director of Finance and Portfolio Strategy for Takeda's Global Plasma-Derived Therapies Business Unit since November 2014, Kerry plays a pivotal role in financial planning and performance analysis. Previously, Kerry served as Associate Director of Financial Controlling Business Partner for the Europe and Canada Business Unit, overseeing financial controls and risk management across 27 commercial entities. Kerry's background in internal audit at Takeda and Shire Pharmaceuticals includes leading numerous financial and compliance audits. Prior to joining Takeda, Kerry worked at World Fuel Services as a Senior Accountant, handling the preparation of financial statements, and at KPMG, providing professional audit services across various industries. Kerry holds a Bachelor of Science in Accounting and Finance from Indiana University Bloomington.
This person is not in any teams
This person is not in any offices
Takeda Pharmaceutical
177 followers
For more than 230 years, Takeda has brought hope to people around the world through its people-centered and innovation-driven approach to science and medicine. As a global pharmaceutical leader, Takeda focuses on solving unmet needs where it can make a real difference—and on putting patients first. Its therapeutics focus is oncology, gastroenterology, and the central nervous system, as well as vaccines.